Feasibility of Cetuximab (ERBITUX) Associated With Concomitant Radio-chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer: a Phase II, Randomised Study.

Trial Profile

Feasibility of Cetuximab (ERBITUX) Associated With Concomitant Radio-chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer: a Phase II, Randomised Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel; Etoposide; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Oct 2012 Status changed from recruiting to completed.
    • 02 Oct 2012 Final results presented at the 37th Congress of the European Society for Medical Oncology.
    • 21 Jun 2012 Additional company (Merck KGaA) added in association as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top